Skip to main content
FDA approves Zydus Cadila's generic anti-diabetes drug
3/15/2019

Zydus Cadila's sitagliptin and metformin hydrochloride extended-release tablets, a generic version of the diabetes drug Janumet XR, has been tentatively approved by the FDA. The drug will be released in three strengths -- 50 mg/500 mg, 50 mg/1,000 mg and 100 mg/1,000 mg.

Full Story: